Citigroup Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $117
Benzinga Newsdesk 52 minutes ago
Analyst RatingsNewsPrice Target
Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $99 to $117.
Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $99 to $117.